NCT01626664 2024-04-25KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)Kyowa Kirin Co., Ltd.Phase 2 Completed71 enrolled 15 charts
NCT01363817 2019-07-30Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaBristol-Myers SquibbPhase 1 Completed31 enrolled